Many lipid-lowering drugs (such as statins, fibrates, and niacin) can reduce ApoCIII levels, and antisense inhibition therapy for ApoCIII can significantly reduce ApoCIII and TG levels in patients with hyperlipidemia (47). The gene discussed is APOC3; the disease is hyperlipidemia.